You just read:

Global DNA Repair Drugs Report: Focus on PARP Inhibitors 2016-2026 - Myriad Genetics and Foundation Medicine Have Emerged as the Major Diagnostic Developers - Research and Markets

News provided by

Research and Markets

22 Jun, 2016, 13:10 BST